Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.54 |
| ▸ | TSHR | P16473 | 2/20 | 0.54 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.51 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.49 |
| ▸ | MEN1 | O00255 | 1/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.47 |
| ▸ | NPC1 | O15118 | 3/20 | 0.47 |
| ▸ | RAB9A | P51151 | 3/20 | 0.47 |
| ▸ | HPGD | P15428 | 1/20 | 0.47 |
| ▸ | TSPO | P30536 | 1/20 | 0.46 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.46 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.45 |
| ▸ | MITF | O75030 | 1/20 | 0.45 |
| ▸ | HTT | P42858 | 1/20 | 0.45 |
| ▸ | MAPT | P10636 | 1/20 | 0.45 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.44 |
| ▸ | PPARG | P37231 | 3/20 | 0.44 |
| ▸ | PPARA | Q07869 | 3/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16965114 | 0.86 | LMNA (0.57) | LMNATSHRSMN1; SMN2L3MBTL1MEN1 | |
| SCHEMBL29728538 | 0.86 | LMNA (0.57) | LMNATSHRSMN1; SMN2L3MBTL1MEN1 | |
| SCHEMBL22372572 | 0.83 | MEN1 (0.50) | LMNATSHRSMN1; SMN2L3MBTL1MEN1 | |
| SCHEMBL22208756 | 0.83 | LMNA (0.59) | LMNATSHRSMN1; SMN2L3MBTL1MEN1 | |
| SCHEMBL31697111 | 0.83 | LMNA (0.59) | LMNATSHRSMN1; SMN2L3MBTL1MEN1 | |
| SCHEMBL13342902 | 0.83 | LMNA (0.55) | LMNATSHRSMN1; SMN2L3MBTL1MEN1 | |
| SCHEMBL29517939 | 0.83 | LMNA (0.54) | LMNATSHRSMN1; SMN2KMT2AKDM4E | |
| SCHEMBL22372583 | 0.83 | LMNA (0.54) | LMNATSHRSMN1; SMN2KMT2AKDM4E | |
| SCHEMBL22208577 | 0.81 | LMNA (0.53) | LMNATSHRSMN1; SMN2L3MBTL1MEN1 | |
| SCHEMBL31697274 | 0.81 | LMNA (0.53) | LMNATSHRSMN1; SMN2L3MBTL1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114478336-B | Process for producing mercaptophenol compound and intermediate therefor | 组合化学工业株式会社 | 2024-05-14 | — | — | CN | disclosed |
| EP-3760613-B1 | METHOD FOR PRODUCING MERCAPTOPHENOL COMPOUND AND INTERMEDIATE OF SAID COMPOUND | KUMIAI CHEMICAL INDUSTRY CO (JP) | 2023-01-25 | — | — | EP | disclosed |
| CN-114478336-A | Process for producing mercaptophenol compound and intermediate therefor | 组合化学工业株式会社 | 2022-05-13 | — | — | CN | disclosed |
| CN-111918862-B | Process for producing mercaptophenol compound and intermediate therefor | 组合化学工业株式会社 | 2022-01-18 | — | — | CN | disclosed |
| EP-3760613-A1 | METHOD FOR PRODUCING MERCAPTOPHENOL COMPOUND AND INTERMEDIATE OF SAID COMPOUND | Kumiai Chemical Industry Co., Ltd. (JP) | 2021-01-06 | — | — | EP | disclosed |
| US-10851052-B2 | Method for producing mercaptophenol compound and intermediate of said compound | KUMIAI CHEMICAL INDUSTRY CO., LTD. (JP) | 2020-12-01 | — | — | US | disclosed |
| CN-111918862-A | Process for producing mercaptophenol compound and intermediate therefor | 组合化学工业株式会社 | 2020-11-10 | — | — | CN | disclosed |
| US-20200277257-A1 | METHOD FOR PRODUCING MERCAPTOPHENOL COMPOUND AND INTERMEDIATE OF SAID COMPOUND | KUMIAI CHEMICAL INDUSTRY CO., LTD. (JP) | 2020-09-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200277257-A1 | METHOD FOR PRODUCING MERCAPTOPHENOL COMPOUND AND INTERMEDIATE OF SAID COMPOUND | MGMT, MPST, TPMT | LMNA 4711/4885TSHR 4118/4885SMN1; SMN2 3955/4885 |
| US-10851052-B2 | Method for producing mercaptophenol compound and intermediate of said compound | MGMT, MPST, TPMT | LMNA 4711/4885TSHR 4118/4885SMN1; SMN2 3955/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.